You are leaving Medscape Education
Cancel Continue
News & Perspective
Drugs & Diseases
CME & Education
Academy
Video
Decision Point

Specialty: Multispecialty
Allergy & Immunology
Anesthesiology
Business of Medicine
Cardiology
Critical Care
Dermatology
Diabetes & Endocrinology
Emergency Medicine
Family Medicine
Gastroenterology
General Surgery
Hematology - Oncology
HIV/AIDS
Hospital Medicine
Infectious Diseases
Internal Medicine
Multispecialty
Nephrology
Neurology
Ob/Gyn & Women's Health
Oncology
Ophthalmology
Orthopedics
Pathology & Lab Medicine
Pediatrics
Plastic Surgery
Psychiatry
Public Health
Pulmonary Medicine
Radiology
Rheumatology
Transplantation
Urology
Interprofessional
Shared Decision Making
Nurses
Pharmacists
Edition: English

Medscape

English
Deutsch
Español
Français
Português
UKNew

Univadis

Sign Up It's Free!
English Edition

Medscape

Univadis

    X
    Univadis from Medscape

    No Results

      Sunday, December 3, 2023
      News & Perspective Drugs & Diseases CME & Education Academy Video Decision Point
      Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
       
       

      CME / ABIM MOC / CE

      Current Challenges in Child and Adolescent Psychiatry

      • Authors: Rachel Brown, MBBS; Jon E. Grant, MD, JD, MPH; Gregory W. Mattingly, MD; Amanda J. Simonton, PhD, APRN, PMHNP-BC; Kristin Sohl, MD, FAAP
      • CME / ABIM MOC / CE Released: 12/21/2022
      • Valid for credit through: 12/21/2023, 11:59 PM EST
      Start Activity

      • Credits Available

        Physicians - maximum of 2.50 AMA PRA Category 1 Credit(s)™

        ABIM Diplomates - maximum of 2.50 ABIM MOC points

        Nurses - 2.50 ANCC Contact Hour(s) (1 contact hours are in the area of pharmacology)

        IPCE: 2.50 Interprofessional Continuing Education (IPCE) credit

        You Are Eligible For

        • Letter of Completion
        • ABIM MOC points

      Target Audience and Goal Statement

      This activity is intended for psychiatrists, neurologists, nurse practitioners (NPs), primary care physicians (PCPs), pediatricians, physician assistants (PAs), nurses, pharmacists, and other healthcare practitioners (HCPs) who provide care to pediatric patients with neuropsychiatric disorders.

      The goal of this activity is for learners to be better able to screen, diagnose, and manage pediatric patients with neuropsychiatric and psychiatric disorders.

      Upon completion of this activity, participants will:

      • Have increased knowledge regarding the
        • Impact of the COVID-19 pandemic on the prevalence of and risks for behavioral health disorders in pediatric patients
        • Recent clinical data on emerging and novel interventions for ADHD
        • Recent clinical data on emerging and novel tools for autism spectrum disorder (ASD) screening and diagnosis
        • Regarding the up-to-date evidence on clinical interventions for pediatric patients with ASD
      • Have greater competence related to
        • Implementing best practices in pharmacologic and non-pharmacologic management of obsessive-compulsive disorder (OCD) in adolescent patients
      • Demonstrate greater confidence in their ability to
        • Incorporate interprofessional strategies into adolescent psychiatric care

      Disclosures

      Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

      All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.

      Disclosures for additional planners can be found here.

      Session and Conference Chair

      • Gregory W. Mattingly, MD

        Associate Clinical Professor
        Washington University School of Medicine
        President, Midwest Research Group
        President-Elect
        APSARD - American Professional Society for ADHD and Related Disorders
        St. Louis, Missouri

        Disclosures

        Gregory W. Mattingly, MD, has the following relevant financial relationships:
        Served as an advisor or consultant for: AbbVie, Inc; Acadia Pharmaceuticals, Inc.; Alkermes, Inc.; Axsome Therapeutics, Inc.; Corium Inc.; Eisai, Inc; Ironshore Pharmaceuticals, Inc.; Intra-Cellular Therapies, Inc; Janssen; Lundbeck, Inc.; Neos Therapeutics, Inc.; Neurocrine Biosciences, Inc.; Noven Pharmaceuticals, Inc.; Otsuka Pharmaceutical Co., Ltd.; Redax; Rhodes Pharmaceuticals L.P.; Roche; Sage Therapeutics; Sunovion Pharmaceuticals, Inc.; Supernus Pharmaceuticals, inc.; Takeda; Teva; Tris Pharma, Inc.
        Received grants for clinical research from: AbbVie, Inc.; Alkermes, Inc.; Corium Inc.; Eisai, Inc.; Intra-Cellular Therapies, Inc.; Ironshore Pharmaceuticals, Inc.; Janssen; Lundbeck, Inc.; Neurocrine Biosciences, Inc.; Noven Pharmaceuticals, inc.; Otsuka Pharmaceutical Co., Ltd.; Sunovion Pharmaceuticals, Inc.; Supernus Pharmaceuticals, Inc.; Takeda; Tris Pharma, Inc.
        Contracted researcher for: AbbVie, Inc.; Acadia Pharmaceuticals, Inc.; Alkermes, Inc.; Akili Interactive Labs, inc.; Axsome Therapeutics, Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Emalex Biosciences; Idorsia Pharmaceuticals, Inc.; Janssen; Karuna Therapeutics; Lumos Labs; Medgenics; NLS-1 Pharma AG; Redax; Relmada Therapeutics, Inc.; Roche; Sage Therapeutics; Sirtsei Pharmaceuticals, Inc.; Sunovion Pharmaceuticals, Inc.; Supernus Pharmaceuticals, Inc.; Takeda; Teva Neuroscience, Inc.

      Faculty

      • Rachel Brown, MBBS

        Professor and Chair
        Psychiatry and Behavioral Sciences
        The University of Kansas School of Medicine
        Wichita, Kansas

        Disclosures

        Rachel Brown, MBBS, has no relevant financial relationships.

      • Jon E. Grant, MD, JD, MPH

        Professor of Psychiatry
        University of Chicago
        Chicago, Illinois

        Disclosures

        Jon E. Grant, MD, JD, MPH, has the following relevant financial relationships:
        Received grants for clinical research from: Biohaven Pharmaceuticals; Otsuka Pharmaceutical Co., Ltd.

      • Amanda J. Simonton, PhD, APRN, PMHNP-BC

        Clinical Assistant Professor
        School of Nursing
        The University of Texas at Austin
        Psychiatric Nurse Practitioner
        Texas Child Study Center
        Dell Children's Medical Center
        Psychiatric Nurse Practitioner
        CARMA Health
        Austin, Texas

        Disclosures

        Amanda J. Simonton, PhD, APRN, PMHNP-BC, has the following relevant financial relationships:
        Served as an advisor or consultant for: Alkermes Inc. (former); Corium Inc. (former)

      • Kristin Sohl, MD, FAAP

        ​Professor
        Department of Child Health
        Executive Director
        Extension for Community Healthcare Outcomes (ECHO) Autism
        University of Missouri
        Columbia, Missouri

        Disclosures

        Kristin Sohl, MD, FAAP, has the following relevant financial relationships:
        Served as an advisor or consultant for: Cognoa, Inc. (former); Quadrant Biosciences
        Received grants for clinical research from: Cognoa, Inc.

      Editor

      • Clinton W. Wright, PharmD, BCPP

        Medical Education Director, Medscape, LLC

        Disclosures

        Clinton W. Wright, PharmD, BCPP, has no relevant financial relationships.

      Compliance Reviewer/Nurse Planner

      • Stephanie Corder, ND, RN, CHCP

        Associate Director, Accreditation and Compliance, Medscape, LLC

        Disclosures

        Stephanie Corder, ND, RN, CHCP, has no relevant financial relationships.

      Peer Reviewer

      This activity has been peer reviewed and the reviewer has no relevant financial relationships.

      Accreditation Statements

      Medscape

      Interprofessional Continuing Education

      In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

      IPCE

      This activity was planned by and for the healthcare team, and learners will receive 2.50 Interprofessional Continuing Education (IPCE) credit for learning and change.

        For Physicians

      • Medscape, LLC designates this enduring material for a maximum of 2.50 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

        Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2.50 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.

        Contact This Provider

        For Nurses

      • Awarded 2.50 contact hour(s) of nursing continuing professional development for RNs and APNs; 1.0 contact hours are in the area of pharmacology.

        Contact This Provider

      For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]

      Instructions for Participation and Credit

      There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

      This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

      Follow these steps to earn CME/CE credit*:

      1. Read about the target audience, learning objectives, and author disclosures.
      2. Study the educational content online or print it out.
      3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

      You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print out the tally as well as the certificates from the CME/CE Tracker.

      *The credit that you receive is based on your user profile.

      < Psychiatry Update Resource Center
      From Medscape Education Psychiatry & Mental Health
      CME / ABIM MOC / CE

      Current Challenges in Child and Adolescent Psychiatry

      Authors: Rachel Brown, MBBS; Jon E. Grant, MD, JD, MPH; Gregory W. Mattingly, MD; Amanda J. Simonton, PhD, APRN, PMHNP-BC; Kristin Sohl, MD, FAAPFaculty and Disclosures

      CME / ABIM MOC / CE Released: 12/21/2022

      Valid for credit through: 12/21/2023, 11:59 PM EST

      processing....

      Contents of This CME Activity

      All sections of this activity are required for credit.

      Unpacking the Impact of COVID-19 on Pediatric Mental Health

      Quantifying COVID-19's impact on youth mental health: Where do we stand 2 years later?
      Amanda J. Simonton, PhD, APRN, PMHNP-BC

      Innovations in ADHD: Updates in Pharmacologic and Nonpharmacologic Therapeutics

      How does life change developmentally for individuals with ADHD? Learn this and more from world-renowned experts
      Gregory W. Mattingly, MD

      Best Practices in OCD Management in Adolescents

      Are you up to date on OCD in adolescents? It's more than just handwashing
      Jon E. Grant, MD, JD, MPH

      Opening the Door to Earlier Recognition: Advancements in the Screening and Diagnosis of Autism Spectrum Disorder

      Developmental surveillance: Can you identify abnormalities in social communication?
      Kristin Sohl, MD, FAAP

      The Management of Autism Spectrum Disorder

      Start low and go slow. Did you know that there are higher rates of sides effects and that responses may be unpredictable?
      Rachel Brown, MBBS
       

      Educational Impact Challenge

      The goal of this activity is for learners to be better able to screen, diagnose, and manage pediatric patients with neuropsychiatric and psychiatric disorders.

      Before you begin this activity, please assess your clinical knowledge by completing this brief survey. Answering these questions again after the activity will allow you to see what you learned and to compare your answers with those of your peers.

      Page 1 of 8
      CME / ABIM MOC / CE Information Download Slides
      • Print
      Find Us On
      About
      About Medscape Privacy Policy Editorial Policy Cookies Terms of Use Advertising Policy Help Center
      Membership
      Become a Member About You Professional Information Newsletters & Alerts Market Research
      App
      Medscape
      WebMD Network
      Medscape Live Events WebMD MedicineNet eMedicineHealth RxList WebMD Corporate Medscape UK
      Editions
      English Deutsch Español Français Português UK
      All material on this website is protected by copyright, Copyright © 1994-2023 by WebMD LLC. This website also contains material copyrighted by 3rd parties.